Device Trial Radar · NCT05977751
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
573
Planned (sponsor's estimate)
Start
Oct 31, 2023
Primary completion
Dec 2029
Study completion Jun 2031
Sponsor
- Lead sponsor
- Femasys Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 4, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated device
- Yes
- Who can join
- Female only, from 21 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.
Conditions
- Contraception
Interventions
FemBlocDevice
Treatment for women who desire non-surgical permanent birth control by occlusion of the fallopian tubes.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pregnancy RateTime frame: one (1) year
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
New Horizons Clinical Trials
Chandler, Arizona · Recruiting
Stanford University
Palo Alto, California · Recruiting
University of California Davis
Sacramento, California · Recruiting
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.